MedPage Today29 分钟
Debate Over Abortion Pill Resurfaces After Makary Is Confirmed to Head FDA
President Donald Trump's pick to lead the FDA, Marty Makary, MD, MPH, was confirmed by the Senate late Tuesday. In recent ...
Consortium advances a test to detect drug-induced liver injury
Predictive Safety Testing Consortium have proposed glutamate dehydrogenase (GLDH) as a more liver-specific biomarker for ...
Novartis Gets FDA Approval for Use of Pluvicto Against Prostate Cancer
Novartis said the U.S. Food and Drug Administration has approved the use of Pluvicto against a certain type of prostate cancer. The drug maker said Friday that the FDA green-lit the use of Pluvicto to ...
CURE1 小时
FDA Expands Pluvicto Indication in Prostate Cancer Subset
FDA expands Pluvicto indication to adults with PSMA+ metastatic castration-resistant prostate cancer previously treated with ...
Stocktwits on MSN1 小时
Milestone Pharmaceuticals Stock Plunges 60% After FDA Declines To Approve Its Cardamyst ...
Shares of Milestone Pharmaceuticals Inc. (MIST) traded 60% lower on Friday after the Food and Drug Administration (FDA) did ...
US FDA declines to approve Milestone's heart rhythm nasal spray; shares halve
Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...
Thousands of pounds of coffee recalled across 15 states after being mislabeled: FDA
Thousands of pounds of coffee have been recalled across 15 states after bags of ground java were incorrectly labeled as ...
Hot Sauce Recall Update as FDA Sets Highest Risk Warning
The U.S. Food and Drug Administration has issued its highest-risk warning for a hot pot sauce recalled earlier this month.
CHMP Recommends Against Approval of Eli Lilly's Kisunla Alzheimer's Drug — Update
Eli Lilly, which is seeking European approval of Kisunla for the treatment of early symptomatic Alzheimer's, said it will seek re-examination by CHMP. The Indianapolis drugmaker said it remains ...
FDA approves first at-home, over-the-counter test for STIs. But there's a catch.
The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway for more to come.
Medscape2 小时
Alzheimer Drug Donanemab Gets No-Go From European Regulator
The EMA has recommended refusing marketing authorization for donanemab, a monoclonal antibody against amyloid beta, in the treatment of Alzheimer's disease.